A test at the clinic confirmed she was pregnant. But when technicians doing an ultrasound found nothing in her uterus, Vise was told the baby was simply “too small to be seen,” even though she was six weeks pregnant and the child of that age and size should have been seen if implanted in the uterus.
. . . The FDA-approved protocol says that patients are to return two days following administration of RU486 to have a doctor administer the prostaglandin, misoprostol. But the clinic told Vise to administer the misoprostol to herself and to come back for a follow up in two weeks.
When she began to experience severe pain and bleeding, Vise called the clinic. They advised her that her symptoms were “normal and routine.” She called back multiple times and got the same answer.
. . . The FDA-approved protocol says that patients are to return two days following administration of RU486 to have a doctor administer the prostaglandin, misoprostol. But the clinic told Vise to administer the misoprostol to herself and to come back for a follow up in two weeks.
When she began to experience severe pain and bleeding, Vise called the clinic. They advised her that her symptoms were “normal and routine.” She called back multiple times and got the same answer.
. . . Admitted [to the hospital] in very critical condition, doctors found through exploratory surgery that Vise had a ruptured ectopic pregnancy. That previously undiscovered rupture led to a massive infection that eventually resulted in a collapse of her vital systems. By Wednesday, September 12, Vise had slipped into a coma. She died later that day. NRLC
No comments:
Post a Comment